
Guardian Pharmacy Services rose 74.5% from $28.33 to $49.43, ahead of the S&P 500's +11.2%. Its worst day was Jan 16 (−8.4%), and its low came Jan 16 at $27.03.
Nov 17, 2025 – Nov 16, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Guardian Pharmacy Services closed at its lowest level of the year, 4.6% below where the year started.
−8.4%, the year's worst day · S&P 500 −0.1%
Guardian Pharmacy Services shares rose 7.2%, while the S&P 500 rose 0.5%.
Story events cover the past 12 months · Times ET
+7.2% · S&P 500 +0.5%
EPS of $0.37 beat the $0.26 estimate on $397.6M revenue (est. $389.3M); FY revenue guidance of $1.4B–$1.4B against the $1.4B consensus.
−0.7% · S&P 500 −1.5%
Guardian Pharmacy Services shares rose 9.0%, while the S&P 500 fell 0.3%.
+9.0% · S&P 500 −0.3%
EPS of $0.29 beat the $0.24 estimate on $336.6M revenue (est. $329.8M); FY revenue guidance of $1.4B–$1.4B against the $1.4B consensus.
−0.8% · S&P 500 −0.3%
Guardian Pharmacy Services shares rose 8.8%, while the S&P 500 fell 0.7%.
+8.8% · S&P 500 −0.7%
EPS of $0.29 beat the $0.26 estimate on $351.8M revenue (est. $340.3M); FY revenue guidance of $1.4B–$1.4B against the $1.4B consensus.
+11.0%, the year's best day · S&P 500 +0.6%
Guardian Pharmacy Services shares fell 6.9%, while the S&P 500 rose 0.5%.
−6.9% · S&P 500 +0.5%
EPS of $0.33 beat the $0.31 estimate on $371.1M revenue (est. $365.4M); FY revenue guidance of $1.4B–$1.5B against the $1.4B consensus.
+6.3% · S&P 500 +0.3%
Where it ended: a close of $49.43 on Nov 16, 2026. Up next: Q4 2026 earnings on Mar 10, 2027 (EPS est. $0.44, revenue est. $393.0M).
Nothing in the past 12 months.
All GRDN dividend historyReplay the year: the line draws itself and stops at each of the 9 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for GRDN and SPY from Benzinga historical bars. Not investment advice.